Trails Edge Biotechnology USA Fund, LP
Amendment
CIK: 0002070467·Pooled Investment Fund·DELAWARE·Filed: Jun 25, 2026
Total Offering
Indefinite
Amount Sold
$205,966,000
Investors
22
First Sale
Jul 1, 2025
Offering Details
- Type
- Pooled Investment Fund
- Exemptions
- Section 3(c), Section 3(c)(7)
- Entity Type
- Limited Partnership
- Year Incorporated
- 2024
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| - Trails Edge Biotechnology Fund GP, LP | |
| - Trails Edge Capital Partners, LP | |
| Ortav Yehudai | |
| Matthew Diaz |
Company
SEC Filing
0001493152-26-030078
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free